한국어
English
日本語
中文(简体)
Inlyta 1 mg (Axitinib)
1mg
Tablet · Prescription medication
Pfizer Korea Co., Ltd.
Axitinib is an anticancer drug used for the treatment of renal cancer that inhibits the growth of cancer cells.
MFDS ingredient code M255256
Axitinib is an anticancer drug that blocks vascular endothelial growth factor receptors. It is primarily used in the treatment of renal cancer and slows cancer progression by preventing the formation of blood vessels that supply nutrients to the cancer cells.
Axitinib blocks signals that promote the formation of blood vessels around the cancer cells. As a result, the supply of oxygen and nutrients to the cancer tissue decreases, inhibiting the growth of cancer cells.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other vascular endothelial growth factor receptor inhibitors, Axitinib has high selectivity, reducing side effects and allowing for effective inhibition of angiogenesis.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
